Aditxt, Inc. is a Delaware-incorporated health innovation company headquartered in Mountain View, California. Through subsidiaries Adimune, Inc. and Pearsanta, Inc., it develops immune modulation therapeutics (ADI platform targeting autoimmune diseases and organ transplant rejection) and mitochondrial DNA-based cancer detection tests. Key product candidates include ADI-100 for type-1 diabetes, psoriasis, and Stiff Person Syndrome, plus prostate cancer and endometriosis diagnostic tests based on the Mitomic Technology platform.
expected 2026-12-23
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-31 | 2025-12-31 | 0001213900-26-037529 | EDGAR | 89K words |
| 2025-03-31 | 2024-12-31 | 0001213900-25-026256 | EDGAR | 105K words |
| 2024-04-16 | 2023-12-31 | 0001213900-24-033466 | EDGAR | 83K words |
| 2023-04-17 | 2022-12-31 | 0001213900-23-030316 | EDGAR | 56K words |
| 2022-03-31 | 2021-12-31 | 0001213900-22-016723 | EDGAR | — |
| 2021-03-25 | 2020-12-31 | 0001213900-21-017776 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-18 | 2025-09-30 | 0001213900-25-111638 | EDGAR | 42K words |
| 2025-08-14 | 2025-06-30 | 0001213900-25-076710 | EDGAR | 34K words |
| 2025-05-15 | 2025-03-31 | 0001213900-25-044298 | EDGAR | 47K words |
| 2024-11-18 | 2024-09-30 | 0001213900-24-099697 | EDGAR | 57K words |
| 2024-08-19 | 2024-06-30 | 0001213900-24-070700 | EDGAR | 48K words |
| 2024-05-20 | 2024-03-31 | 0001213900-24-045191 | EDGAR | 39K words |
| 2023-11-14 | 2023-09-30 | 0001213900-23-087099 | EDGAR | 34K words |
| 2023-08-14 | 2023-06-30 | 0001213900-23-067112 | EDGAR | 29K words |
| 2023-05-15 | 2023-03-31 | 0001213900-23-039839 | EDGAR | 22K words |
| 2022-11-14 | 2022-09-30 | 0001213900-22-072173 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0001213900-22-048035 | EDGAR | — |
| 2022-05-16 | 2022-03-31 | 0001213900-22-027113 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-23 | 0001213900-26-102469 | EDGAR | 1K words |
| 2026-08-19 | 0001213900-26-091703 | EDGAR | 1K words |
| 2026-07-17 | 0001213900-26-079025 | EDGAR | 4K words |
| 2026-04-02 | 0001213900-26-038906 | EDGAR | 1K words |
| 2026-03-30 | 0001213900-26-035973 | EDGAR | 1K words |
| 2026-03-13 | 0001213900-26-027281 | EDGAR | 1K words |
| 2026-03-05 | 0001213900-26-023888 | EDGAR | 1K words |
| 2026-02-13 | 0001213900-26-016565 | EDGAR | 1K words |
| 2026-01-30 | 0001213900-26-010217 | EDGAR | 1K words |
| 2026-01-28 | 0001213900-26-008539 | EDGAR | 1K words |
287 total filings indexed. 259 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001726711 |
| Ticker | ADTX |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Headquarters | Mountain View, California |
| Website | https://www.aditxt.com |
| Listed | 2020-06-30 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/ADTX (~200 tokens, structured JSON with cryptographic provenance)